FANJ
WST icon

Financial Architects (New Jersey)’s West Pharmaceutical WST Stock Holding History

Financial Architects (New Jersey)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-84
Closed -$3K – 574
2013
Q3 		$3K Buy
+84
New +$3.21K ﹤0.01% 658

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Architects (New Jersey)'s WST Position: Q4 2013 in Review

Financial Architects (New Jersey) sold out of West Pharmaceutical (WST) in Q4 2013, closing a stake of 84 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in WST in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 230 funds tracked by Wall St. Rank hold WST as of Q4 2013.

  • Financial Architects (New Jersey) reported no remaining West Pharmaceutical position as of Q4 2013 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 84 West Pharmaceutical shares in Q4 2013, an estimated $3K.
  • Financial Architects (New Jersey) first reported a position in West Pharmaceutical in Q3 2013 and held it in 1 quarter.
  • Financial Architects (New Jersey)'s West Pharmaceutical position peaked at $3K in Q3 2013.
  • 230 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2013.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2013, filed 7 Feb 2014.